These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7578378)

  • 21. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial.
    Vose JM; Pandite AN; Beveridge RA; Geller RB; Schuster MW; Anderson JE; LeMaistre CF; Ahmed T; Granena A; Keating A; Fernandez Ranada JM; Stiff PJ; Tabbara I; Longo W; Copelan EA; Nichols C; Smith A; Topolsky DL; Bierman PJ; Lebsack ME; Lange M; Garrison L
    J Clin Oncol; 1997 Apr; 15(4):1617-23. PubMed ID: 9193361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron.
    Henry DH; Dahl NV; Auerbach MA
    Am J Hematol; 2012 Mar; 87(3):308-10. PubMed ID: 22262486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
    Nowrousian MR
    Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin and GM-CSF following autologous bone marrow transplantation.
    Pedrazzini A
    Eur J Cancer; 1993; 29A Suppl 2():S15-7. PubMed ID: 8398360
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of erythropoietin in oncology].
    Rosso R; Del Mastro L; Venturini M; Bergaglio M; Pasquetti W; Garrone O
    Tumori; 1997; 83(4 Suppl 2):S26-30. PubMed ID: 9487381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
    Vannucchi AM; Bosi A; Linari S; Guidi S; Longo G; Lombardini L; Mariani MP; Saccardi R; Laszlo D; Rossi Ferrini P
    Haematologica; 1997; 82(1):53-6. PubMed ID: 9107083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial.
    Vannucchi AM; Bosi A; Ieri A; Guidi S; Saccardi R; Lombardini L; Linari S; Laszlo D; Longo G; Rossi-Ferrini P
    Bone Marrow Transplant; 1996 Apr; 17(4):527-31. PubMed ID: 8722349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor.
    Sieff C; Guinan E
    Stem Cells; 1993 Jul; 11 Suppl 2():113-22. PubMed ID: 7691316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy.
    Glaspy J; Jadeja JS; Justice G; Kessler J; Richards D; Schwartzberg L; Rigas J; Kuter D; Harmon D; Prow D; Demetri G; Gordon D; Arseneau J; Saven A; Hynes H; Boccia R; O'Byrne J; Colowick AB
    Br J Cancer; 2001 Apr; 84 Suppl 1(Suppl 1):17-23. PubMed ID: 11308270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study.
    Kurz Ch; Marth Ch; Windbichler G; Lahousen M; Medl M; Vavra N; Sevelda P
    Gynecol Oncol; 1997 Jun; 65(3):461-6. PubMed ID: 9190976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer.
    Smith RE; Jaiyesimi IA; Meza LA; Tchekmedyian NS; Chan D; Griffith H; Brosman S; Bukowski R; Murdoch M; Rarick M; Saven A; Colowick AB; Fleishman A; Gayko U; Glaspy J
    Br J Cancer; 2001 Apr; 84 Suppl 1(Suppl 1):24-30. PubMed ID: 11308271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancer.
    Cheer SM; Wagstaff AJ
    Drugs; 2004; 64(3):323-46. PubMed ID: 14871172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human erythropoietin in the treatment of anemic patients with hematological malignancies.
    Kasper C
    Ann Hematol; 2001 Jun; 80(6):319-29. PubMed ID: 11475144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietin and chronic lymphocytic leukemia.
    Mauro FR; Gentile M; Foa R
    Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy.
    Vansteenkiste J; Pirker R; Massuti B; Barata F; Font A; Fiegl M; Siena S; Gateley J; Tomita D; Colowick AB; Musil J;
    J Natl Cancer Inst; 2002 Aug; 94(16):1211-20. PubMed ID: 12189224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human erythropoietin as adjuvant treatment for autologous blood donation. A prospective study.
    Beris P; Mermillod B; Levy G; Laubriat M; Soulier-Lauper M; Tullen E; Hugli A; Miescher PA
    Vox Sang; 1993; 65(3):212-8. PubMed ID: 8249364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia in children with malignant solid tumours.
    Csáki C; Ferencz T; Schuler D; Borsi JD
    Eur J Cancer; 1998 Feb; 34(3):364-7. PubMed ID: 9640223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes.
    Stein RS; Abels RI; Krantz SB
    Blood; 1991 Oct; 78(7):1658-63. PubMed ID: 1912554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoiesis-stimulating agents: favorable safety profile when used as indicated.
    Nowrousian MR; Dunst J; Vaupel P
    Strahlenther Onkol; 2008 Mar; 184(3):121-36. PubMed ID: 18330508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum erythropoietin levels in allogeneic, non T-depleted bone marrow transplantation, and the effects of rhEpo administration.
    Bosi A; Vannucchi AM; Grossi A; Guidi S; Rafanelli D; Saccardi R; Ferrini PR
    Bone Marrow Transplant; 1991; 7 Suppl 2():87. PubMed ID: 1878736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.